# Single Ascending Dose Study(SAD),Multiple Ascending Dose Study(MAD) , High-fat Diet Study (FE) of TJ0113 Capsules in Healthy Subjects

> **NCT07394452** · PHASE1 · COMPLETED · sponsor: **Hangzhou PhecdaMed Co., Ltd.** · enrollment: 130 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** TJ0113 Capsules
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07394452
- **Lead sponsor:** Hangzhou PhecdaMed Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-04
- **Primary completion:** 2024-02-05
- **Final completion:** 2024-04-03
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07394452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07394452, "Single Ascending Dose Study(SAD),Multiple Ascending Dose Study(MAD) , High-fat Diet Study (FE) of TJ0113 Capsules in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07394452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*